These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1418 related items for PubMed ID: 27548033

  • 21. Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens.
    Zeng W, Su M, Anderson KS, Sasada T.
    Immunobiology; 2014 Aug; 219(8):583-92. PubMed ID: 24713579
    [Abstract] [Full Text] [Related]

  • 22. Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene.
    Iwabuchi M, Narita M, Uchiyama T, Iwaya S, Oiwa E, Nishizawa Y, Hashimoto S, Bonehill A, Kasahara N, Takizawa J, Takahashi M.
    Mol Med Rep; 2015 Aug; 12(2):2443-50. PubMed ID: 25936433
    [Abstract] [Full Text] [Related]

  • 23. Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cells.
    Tanimoto K, Muranski P, Miner S, Fujiwara H, Kajigaya S, Keyvanfar K, Hensel N, Barrett AJ, Melenhorst JJ.
    Cytotherapy; 2014 Jan; 16(1):135-46. PubMed ID: 24176543
    [Abstract] [Full Text] [Related]

  • 24. A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.
    Hasan AN, Kollen WJ, Trivedi D, Selvakumar A, Dupont B, Sadelain M, O'Reilly RJ.
    J Immunol; 2009 Aug 15; 183(4):2837-50. PubMed ID: 19635907
    [Abstract] [Full Text] [Related]

  • 25. Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy.
    Foster AE, Gottlieb DJ, Marangolo M, Bartlett A, Li YC, Barton GW, Romagnoli JA, Bradstock KF.
    J Hematother Stem Cell Res; 2003 Feb 15; 12(1):93-105. PubMed ID: 12662440
    [Abstract] [Full Text] [Related]

  • 26. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.
    Takeda Y, Kataoka K, Yamagishi J, Ogawa S, Seya T, Matsumoto M.
    Cell Rep; 2017 May 30; 19(9):1874-1887. PubMed ID: 28564605
    [Abstract] [Full Text] [Related]

  • 27. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
    Garcia-Bates TM, Palma ML, Shen C, Gambotto A, Macatangay BJC, Ferris RL, Rinaldo CR, Mailliard RB.
    J Virol; 2019 Mar 01; 93(5):. PubMed ID: 30541848
    [Abstract] [Full Text] [Related]

  • 28. Identification of a novel HLA-A*24:02-restricted adenovirus serotype 11-specific CD8+ T-cell epitope for adoptive immunotherapy.
    Imahashi N, Nishida T, Ito Y, Kawada J, Nakazawa Y, Toji S, Suzuki S, Terakura S, Kato T, Murata M, Naoe T.
    Mol Immunol; 2013 Dec 01; 56(4):399-405. PubMed ID: 23911395
    [Abstract] [Full Text] [Related]

  • 29. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.
    Masuoka M, Yoshimuta T, Hamada M, Okamoto M, Fumimori T, Honda J, Oizumi K, Itoh K.
    Viral Immunol; 2001 Dec 01; 14(4):369-77. PubMed ID: 11792066
    [Abstract] [Full Text] [Related]

  • 30. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N, Poirier N, Hulin P, Coulon F, Mary C, Ville S, Vie H, Clémenceau B, Blancho G, Vanhove B.
    PLoS One; 2013 Dec 01; 8(12):e83139. PubMed ID: 24376655
    [Abstract] [Full Text] [Related]

  • 31. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
    Gu WY, Cao XS, Qiu GQ, Chen ZX, Sheng LX, Xie XB, He J, Cen JN, Shen HL.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 28; 85(49):3475-80. PubMed ID: 16686063
    [Abstract] [Full Text] [Related]

  • 32. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z, Moutaftsi M, Borysiewicz LK.
    J Immunol; 2001 May 01; 166(9):5695-703. PubMed ID: 11313411
    [Abstract] [Full Text] [Related]

  • 33. CD80 Expressed by CD8+ T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8+ T Cells.
    Rollins MR, Gibbons Johnson RM.
    J Immunol Res; 2017 May 01; 2017():7659462. PubMed ID: 29181416
    [Abstract] [Full Text] [Related]

  • 34. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP, Keyvanfar K, Barrett AJ.
    J Immunother; 2006 May 01; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [Abstract] [Full Text] [Related]

  • 35. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
    Abu-Khader A, Krause S.
    Eur J Haematol; 2013 Dec 01; 91(6):534-45. PubMed ID: 23952609
    [Abstract] [Full Text] [Related]

  • 36. PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.
    Zhao Y, Lee CK, Lin CH, Gassen RB, Xu X, Huang Z, Xiao C, Bonorino C, Lu LF, Bui JD, Hui E.
    Immunity; 2019 Dec 17; 51(6):1059-1073.e9. PubMed ID: 31757674
    [Abstract] [Full Text] [Related]

  • 37. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy.
    Chen FE, Aubert G, Travers P, Dodi IA, Madrigal JA.
    Cytotherapy; 2002 Dec 17; 4(1):41-8. PubMed ID: 11953040
    [Abstract] [Full Text] [Related]

  • 38. The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion.
    Hofmeyer KA, Jeon H, Zang X.
    J Biomed Biotechnol; 2011 Dec 17; 2011():451694. PubMed ID: 21960736
    [Abstract] [Full Text] [Related]

  • 39. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
    Le Goux C, Damotte D, Vacher S, Sibony M, Delongchamps NB, Schnitzler A, Terris B, Zerbib M, Bieche I, Pignot G.
    Urol Oncol; 2017 May 17; 35(5):257-263. PubMed ID: 28291636
    [Abstract] [Full Text] [Related]

  • 40. Use of Engineered Exosomes Expressing HLA and Costimulatory Molecules to Generate Antigen-specific CD8+ T Cells for Adoptive Cell Therapy.
    Kim S, Sohn HJ, Lee HJ, Sohn DH, Hyun SJ, Cho HI, Kim TG.
    J Immunother; 2017 Apr 17; 40(3):83-93. PubMed ID: 28099196
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 71.